MET variant as a prognostic marker in clear cell renal cell carcinoma

Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Dissecting the biology of the androgen receptor pathway

The role of molecular biology in the Identification of predictive factors for prostate cancer incidence

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

mCRPC: Challenges and opportunities in a booming area

Understanding the biology of the disease to guide treatment choices

Predictors of response to mCRPC therapy: where do we stand?

Managing mCRPC in daily practice: a pragmatic approach

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

Immunotherapy in metastatic kidney cancer

Oncology organisations in India and bone health in prostate and breast cancer